Anemia

Anemia is defined as a decrease in the quantity of circulating red blood cells (RBC), represented by a reduction in hemoglobin concentration (Hb), hematocrit (Hct), or RBC count. It is a common condition that can be caused by inadequate RBC production, excessive RBC destruction, or blood loss. The most common cause is iron deficiency. Clinical features, if present, are mostly nonspecific and may include fatigue, dyspnea, conjunctival pallor, and tachycardia. Once anemia has been established, the mean corpuscular volume (MCV) should be checked to distinguish between microcytic, normocytic, and macrocytic anemia and to determine the next diagnostic steps. Reticulocyte count can also be used to evaluate the bone marrow response. Treatment depends on the form of anemia and underlying condition. Acute and/or severe cases of anemia may require transfusion of packed red blood cells.

See basics of hematology, transfusion, and iron deficiency anemia for more information.

• Definition: a decrease in the absolute number of circulating RBCs; exact cutoffs vary from source to source.
• WHO criteria for anemia ^[1]
  • Men: Hb < 13.5 g/dL
  • Women: Hb < 12 g/dL
  • Children
    • 6–59 months: < 11 g/dL
    • 5–11 years: < 11.5 g/dL
    • 12–14 years: < 12.0 g/dL
• Revised WHO/National Cancer Institute ^[2]
  • Men: Hb < 14 g/dL
  • Women: Hb < 12 g/dL
• American Society of Hematology ^[3]
  • Men: Hb < 13.5 g/dL
  • Women: Hb < 12 g/dL
• US National Health and Nutrition Examination Survey: children aged 12–35 months: Hb < 11 g/dL

Anemia may be classified into several subtypes based on the following methods:

• Morphology/size of RBCs (the classification most widely used) ^[4]
• Time course: acute vs. chronic
• Inheritance: inherited vs. acquired
• Etiology: primary vs. secondary
• RBC proliferation: hypoproliferative (decreased RBC production) vs. hyperproliferative (increased RBC destruction or blood loss)

Both iron deficiency anemia and anemia of chronic disease can manifest with normocytic anemia in the initial phase and microcytic anemia later on.

Bone marrow failure (e.g., due to myeloproliferative malignancy, myelodysplastic syndrome) can manifest with microcytic, normocytic, or macrocytic anemia.

The causes of microcytic anemia can be remembered with IRON LAST: IRON deficiency, Lead poisoning, Anemia of chronic disease, Sideroblastic anemia, Thalassemia.

References:^[5][6][7]

• Asymptomatic
• Pallor; (e.g., on mucous membranes, conjunctivae)
• Exertional dyspnea; and fatigue
• Pica (craving for ice or dirt)
• Jaundice (in hemolytic anemia)
• Muscle cramps
• Growth impairment (chronic anemia)
• Worsening of angina pectoris
• Features of hyperdynamic state
  • Bounding pulses
  • Tachycardia/palpitations
  • Flow murmur
  • Pulsatile sound in the ear
  • Possibly heart failure (anemia-induced heart failure)
• Features of extramedullary hematopoiesis may be present in certain severe, chronic forms of anemia (e.g., thalassemia, myelofibrosis).
  • Hepatosplenomegaly
  • Paravertebral mass
  • Widening of diploic spaces of the skull

Pulse acceleration is often the first sign of hemodynamically relevant blood loss.

CBC with differential

Initial test to confirm and classify anemia.

• RBC indices: MCV is the most important parameter in the diagnostic workup of anemia.
• Based on MCV, further testing should be performed to determine the underlying cause.
• Abnormalities in platelet count, WBC count, and WBC differential may provide signs of the underlying diagnosis. ^[8]
  • Abnormal leukocytes may suggest bone marrow failure or bone marrow malignancy (e.g., aplastic anemia, leukemia, myelodysplastic).
  • Pancytopenia can result from several etiologies (e.g., peripheral cell destruction or sequestration in hypersplenism, aplastic anemia, infection).

Microcytic anemia (MCV < 80 fL) ^[8][9]

• Iron studies: initial investigation for microcytic anemia
  • ↓ Ferritin OR normal/↑ ferritin and ↑ TIBC: iron deficiency anemia (see diagnosis of iron deficiency anemia)
  • Normal/↑ ferritin and ↓ TIBC: anemia of chronic disease ^[10]
  • Serum iron levels are decreased in iron deficiency anemia and anemia of chronic disease.
• Peripheral blood smear (PBS), reticulocyte count, RDW: not routinely required to evaluate microcytic anemia because findings are often nonspecific
  • PBS findings may suggest a specific etiology.
  • Reticulocyte count
    • Low reticulocyte count (< 2%): iron deficiency anemia, thalassemia trait, anemia of chronic disease, sideroblastic anemia, and lead poisoning
    • High reticulocyte count (> 2%): thalassemia
  • RDW: typically high in iron deficiency anemia and sideroblastic anemia
• Hemoglobin electrophoresis: obtain if serum iron levels, TIBC, and TfS are normal or elevated
  • Normal hemoglobin A2: sideroblastic anemia, α-thalassemia trait
  • Increased hemoglobin A2: β-thalassemia trait
  • Other hemoglobinopathies (e.g., hemoglobin E, hemoglobin C)
• Bone marrow biopsy: consider if the following are identified ^[9]
  • Ringed sideroblasts on PBS (see sideroblastic anemia, myelodysplastic syndromes)
  • Unexplained thrombocytopenia, leukocytopenia, or pancytopenia
  • Numerous immature forms of blood cells on CBC and/or PBS
• Serum lead level: consider in patients with basophilic stippling but no ringed sideroblasts on PBS (see lead poisoning)

Iron deficiency anemia and thalassemia trait are the most common causes of microcytic anemia. ^[9]

Basophilic stippling on peripheral blood smear suggests lead poisoning or sideroblastic anemia. Because ringed sideroblasts are not usually seen in lead poisoning, they can help to distinguish between this condition and sideroblastic anemia.

While decreased ferritin confirms the diagnosis of iron deficiency anemia, elevated serum ferritin does not rule it out.

Macrocytic anemia (MCV > 100 fL) ^{[8][11][12][13]}

• Peripheral blood smear (PBS): initial investigation for macrocytic anemia to look for megaloblastic changes (hypersegmented neutrophils)
  • Hypersegmented neutrophils (> 5 lobes): megaloblastic anemia
  • No hypersegmented neutrophils: nonmegaloblastic anemia

Evaluation of megaloblastic macrocytic anemia

• Vitamin B₁₂ and folate levels: obtain in all patients with megaloblastic changes on PBS. ^[14][15]
  • Vitamin B₁₂ levels < 200 pg/mL: vitamin B₁₂ deficiency (see “Diagnostics” in vitamin B₁₂ deficiency for further workup)
  • Folate < 2 ng/mL: folate deficiency
• Serum homocysteine and methylmalonic acid levels: obtain in patients with borderline serum vitamin B₁₂ and/or folate levels
  • Normal methylmalonic acid but ↑ homocysteine levels: folic acid deficiency
  • ↑ Methylmalonic acid, normal/↑ homocysteine: vitamin B₁₂ deficiency ^[12]
• Bone marrow biopsy: consider if any of the following are present ^[12]
  • Normal vitamin B₁₂ and folate levels
  • Normal methylmalonic acid and homocysteine levels
  • Unexplained thrombocytopenia, leukocytopenia, or pancytopenia
  • Numerous immature forms of blood cells on CBC and/or PBS
• Additional evaluation: : consider urine orotic acid levels if orotic aciduria is suspected (extremely rare)

Serum methylmalonic acid levels are normal in folic acid deficiency and elevated in vitamin B₁₂ deficiency. Serum homocysteine levels are elevated in both.

Evaluation of nonmegaloblastic macrocytic anemia ^[8][12]

• Reticulocyte count: in all patients with nonmegaloblastic macrocytic anemia to evaluate bone marrow response
  • Normal/low reticulocyte count (< 2%)
    • Obtain a detailed drug and alcohol use history. ^[12]
    • Consider TSH, hepatic panel.
  • High reticulocyte count (> 2%)
    • Reassess history for evidence of acute or chronic blood loss.
    • Check hemolysis labs: ↓ haptoglobin, ↑ LDH, ↑ unconjugated bilirubin suggest a hemolytic anemia
• Additional evaluation: consider the following if reticulocyte count and metabolic panels are normal and there is no history of drug/alcohol use
  • Hemoglobin electrophoresis: ↑ HbF level indicates Diamond-Blackfan anemia
  • Bone marrow biopsy
    • Hypercellular marrow with dysplasia of all three cell lines: myelodysplastic syndrome
    • Hypocellular fat-filled marrow : aplastic anemia
    • Absent or sparse erythroid precursors: pure red cell aplasia

The most common causes of macrocytosis are chronic alcohol consumption, vitamin B12 and/or folate deficiency, and certain medications. ^[12]

Normocytic anemia (MCV 80–100 fL) ^{[8][11][13][16]}

• Reticulocyte count: in all patients with normocytic anemia to evaluate bone marrow response
  • Normal/low reticulocyte count (< 2%) indicates ineffective or decreased RBC production (hypoproliferative anemia)
    • Iron studies: to evaluate for iron deficiency anemia and/or anemia of chronic disease (see microcytic anemia)
    • Vitamin B₁₂ and folate levels (see megaloblastic macrocytic anemia)
    • Basic metabolic panel (BMP), LFTs, thyroid studies: if iron studies and B₁₂ and folate levels are normal ^[8]
    • Serum erythropoietin levels: consider if BUN and/or creatinine levels are abnormal ^[17]
  • High reticulocyte count (> 2%) ^[13]
    • Reassess history for evidence of acute or chronic blood loss.
    • Check hemolysis labs: ↓ haptoglobin, ↑ LDH, ↑ unconjugated bilirubin suggest a hemolytic anemia
• Bone marrow aspirate and biopsy: consider in hypoproliferative anemia with normal nutritional assays and metabolic panels ^[8]

Additional diagnostics

Peripheral blood smear

• Manual examination of a peripheral blood sample under a microscope
• May reveal classic pathologic RBC forms, which can be used to identify certain types of anemia that automated RBC indices cannot (e.g., schistocytes in hemolytic anemia)
• See erythrocyte morphology.

Bone marrow biopsy

• Manual examination of bone marrow aspirate sample under a microscope
• Rarely used in the workup of anemia
• Indications include pancytopenia and/or abnormal cells on the CBC or peripheral blood smear (e.g., blasts)
• Prussian blue staining if sideroblastic anemia is suspected (see above)
• Can be used to diagnose:
  • Aplastic anemia
  • Myelodysplastic syndromes
  • Myeloproliferative neoplasm
  • Malignant invasion of the bone marrow

Imaging

• Imaging is not routinely indicated for the workup of anemia unless bleeding is suspected.
• Consider endoscopy and/or colonoscopy in patients with anemia and positive FOBT.
• Consider abdominal ultrasound to evaluate for hypersplenism, liver disease, or renal disease.
• Consider CT and/or PET scan if malignancy is suspected.

• Identify and treat the underlying cause
• Blood transfusion with RBCs for severe anemia:
  • Hb ≤ 7 g/dL
  • Hb ≤ 8 g/dL if the patient either has a preexisting cardiovascular disease or is undergoing cardiac or orthopedic surgery
  • See transfusion for further details
• Consider hospital admission or observation in: ^[18]
  • Acutely symptomatic anemia
  • Actively bleeding patient, as clinically indicated
  • Patients requiring blood transfusion
• Bone marrow transplantation may be indicated in certain cases (e.g., aplastic anemia).

• IV access
• IV fluid resuscitation if the patient is hypotensive or tachycardic
• Type and screen with crossmatching
• Consent patient for blood transfusion.
• Obtain blood for further diagnostic workup of anemia before initiating transfusion.
• Consider indications for transfusion of packed RBCs.
• Consider transfusion of other blood components, if indicated (e.g., platelets, fresh frozen plasma; see transfusion).
• Identify and treat the underlying cause.
• Serial blood pressure monitoring, continuous pulse oximetry
• Supplemental oxygen as needed

• Description: pancytopenia caused by bone marrow insufficiency ^[19]
• Etiology
  • Idiopathic in > 50% of cases
    • Possibly immune-mediated
    • May follow acute hepatitis (hepatitis-associated aplastic anemia)
  • Medication side effects: carbamazepine, methimazole, NSAIDs, chloramphenicol, propylthiouracil, sulfa drugs, cytostatic drugs (esp. alkylating agents and antimetabolites)
  • Toxins: benzene, cleaning solvents, insecticides, toluene
  • Ionizing radiation
  • Viruses: parvovirus B19, HBV, EBV, CMV, HIV
  • Fanconi anemia ^[20][21]
    • Hereditary autosomal recessive disorder due to a DNA crosslink repair defect resulting in bone marrow failure
    • Skeletal and organ abnormalities: short stature, hypo- and hyperpigmentation, cafe-au-lait spots, microcephaly, developmental delay, thumb and forearm malformations, kidney, GI, heart, eye, and ear abnormalities
    • Laboratory tests show pancytopenia and normocytic or macrocytic anemia.
    • ∼ 50% of patients with Fanconi anemia will develop acute myeloid leukemia or myelodysplastic syndromes in early adulthood.
• Clinical features
  • Fatigue, malaise
  • Pallor
  • Purpura, petechiae, mucosal bleeding
  • Infection
• Diagnostics
  • CBC:
    • Pancytopenia (in contrast to aplastic crisis characterized by anemia only)
    • Normocytic or macrocytic anemia
  • Reticulocyte count: low
  • EPO level: high
  • Bone marrow biopsy findings
    • Hypocellular fat-filled marrow (dry bone marrow tap)
    • RBCs normal morphology
• Treatment
  • Cessation of the causative agent
  • Supportive therapy
    • Treatment of infections
    • Blood transfusion
    • Platelet transfusion
  • Bone marrow stimulants (e.g., GM-CSF, eltrombopag)
  • Immunosuppressive therapy
    • Cyclosporine
    • Antithymocyte globulin (ATG)
    • Tacrolimus
    • Alemtuzumab
  • Consider hematopoietic cell transplantation (HCT) in young patients. ^[22]

Agents that can cause aplastic anemia: Can't Make New Blood Cells Properly = Carbamazepine, Methimazole, NSAIDs, Benzenes, Chloramphenicol, Propylthiouracil

References: ^{[23][24][25][26][27]}

• Description: anemia due to chronic inflammation
• Epidemiology: second most common anemia ^[28]
• Pathophysiology: inflammation → increase in cytokines (esp. IL-6) and hepcidin → results in the outcomes listed below:
  • Reduced iron release from macrophages in the reticuloendothelial system and reduced intestinal iron absorption → reduced iron available systemically
  • Reduced response (of production) to erythropoietin (EPO) and relative reduction of EPO levels → reduced RBC synthesis
  • Reduced erythrocyte survival and lifespan
• Etiology
  • Inflammation (e.g., rheumatoid arthritis, systemic lupus erythematosus)
  • Malignancy (e.g., lung cancer, breast cancer, lymphoma)
  • Chronic infections (e.g., tuberculosis)
• Diagnostics
  • CBC: normocytic anemia (early phase) → microcytic anemia (later phase)
  • Low iron
  • Low iron saturation
  • Low total iron binding capacity (TIBC)
  • High serum ferritin
  • Low reticulocyte count
• Treatment:
  • Treat the underlying cause
  • Blood transfusion if required (see transfusion for indications for blood transfusion)
  • EPO in chronic incurable diseases (e.g., chronic kidney disease)

References:^[29]

• Description: : anemia caused by defective heme metabolism, which leads to iron trapping inside the mitochondria ^[30]
• Etiology
  • Inherited: X-linked sideroblastic anemia due to a δ-ALA-synthase gene defect
  • Acquired
    • Vitamin B₆ deficiency
    • Lead poisoning
    • Alcohol use disorder
    • Drugs (e.g., chloramphenicol, isoniazid , linezolid)
    • Copper deficiency
    • Myelodysplastic syndrome
    • Malignancy
• Diagnostics
  • CBC: microcytic anemia
  • Serum iron studies
    • High ferritin
    • High iron
    • High transferrin saturation
    • Normal/low TIBC
  • Peripheral blood smear
    • Basophilic stippling of RBCs
    • Normocytes/macrocytes (more common in acquired etiologies)
  • Prussian blue staining of bone marrow: ringed sideroblasts
• Treatment
  • Cessation of the offending agent
  • Pyridoxine (B₆) supplementation (a cofactor for δ-ALA synthase)

References: ^[31]

• Description: normocytic, normochromic anemia characterized by a severe reduction in circulating reticulocytes and marked reduction or absence of erythroid precursors in the bone marrow ^[32]
• Pathophysiology: : thought to be related to abnormal T-cell function and IgG antibodies that target erythroblasts and erythropoietin
• Etiology
  • Acquired
    • Most often idiopathic
    • Possible associated conditions
      • Thymoma
      • Myelodysplastic syndrome
      • Adverse drugs effects (e.g., from phenytoin, chloramphenicol)
      • Parvovirus B19 infection
      • Autoimmune disorders (e.g., type 1 diabetes, thyroiditis, rheumatoid arthritis)
  • Congenital: Diamond-Blackfan anemia (DBA) ^[33]
    • Intrinsic defect of erythroid progenitor cells → ↑ apoptosis
    • Rapid onset of macrocytic (non-megaloblastic) anemia in infancy (usually diagnosed within the first year of life)
    • Additional clinical features (physical abnormalities manifest in ∼ 50% of patients)
      • Short stature, webbed neck
      • Upper extremity malformations (e.g., triphalangeal thumbs)
      • Microcephaly, micrognathia
      • Hypertelorism, flat nasal bridge, cleft palate
    • Electrophoresis
      • Elevated HbF levels
      • Low total Hb levels
    • Treatment ^[34]
      • Chronic red cell transfusions
      • Corticosteroids
      • Hematopoietic stem cell transplantation
• Diagnosis
  • Low reticulocyte count
  • Bone marrow biopsy shows marked reduction or absence of erythroid precursors.
• Treatment
  • Treatment of the underlying cause (e.g., cessation of possible offending agents, thymectomy)
  • Red blood cell transfusion for symptomatic patients
  • Immunosuppressive and/or cytotoxic agents (e.g., glucocorticoids, cyclosporine, cyclophosphamide)

• Description: acute anemia due to blood loss
• Etiology: any cause of bleeding can cause acute blood loss anemia
• Clinical features: May be asymptomatic or have symptoms of anemia (see above) ^[16]
• Diagnostics ^[8][16]
  • Routine laboratory studies
    • CBC: ↓ or normal Hb
      • Usually normocytic anemia
      • Compare to prior studies, if available.
      • Check platelets for thrombocytopenia.
    • Type and screen with crossmatching
    • Coagulation panel
    • Blood for potential further studies based on CBC should be drawn before blood transfusion (draw and hold).
  • Imaging: Modality depends on the pretest probability of the suspected site of bleeding.
    • CT of soft tissue if there is concern for intramuscular bleeding.
    • Abdominal/pelvic CT if there is concern for intra-abdominal bleeding.
    • Chest radiography and/or chest CT if there is concern for a pulmonary source (See “Diagnostics” in pleural effusion and in hemothorax).
    • Endoscopy and/or colonoscopy if there is concern for a GI bleed. (See ''Diagnostics'' in gastrointestinal bleeding)
• Treatment
  • Identify and treat the underlying cause
  • Blood transfusion

Hemoglobin and hematocrit levels can initially be normal in acute hemorrhage, even if there has already been significant blood loss. They will eventually decrease after plasma volume has been restored either spontaneously or via IV fluid resuscitation.

• One-Minute Telegram 31-2021-1/3: Bariatric surgery associated with very high risk of long-term anemia

Interested in the newest medical research, distilled down to just one minute? Sign up for the One-Minute Telegram in “Tips and links” below.

1. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity.. http://www.who.int/vmnis/indicators/haemoglobin.pdf. Updated: January 1, 2011. Accessed: May 5, 2019.
2. Rodgers et al. Cancer- and chemotherapy-induced anemia.. J Natl Compr Canc Netw. 2008; 6 (6): p.536-64.
3. Anemia. https://www.hematology.org/Patients/Anemia/. . Accessed: May 5, 2019.
4. Buttarello M. Laboratory diagnosis of anemia: are the old and new red cell parameters useful in classification and treatment, how?. Int J Lab Hematol. 2016; 38 Suppl 1 : p.123-32. doi: 10.1111/ijlh.12500 . | Open in Read by QxMD
5. Agabegi SS, Agabegi ED. Step-Up To Medicine. Wolters Kluwer Health ; 2015
6. Schrier SL. Approach to the adult patient with anemia. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/approach-to-the-adult-patient-with-anemia?source=search_result&search=anemia&selectedTitle=1~150.Last updated: December 19, 2016. Accessed: February 8, 2017.
7. Benz EJ. Clinical Manifestations and Diagnosis of the Thalassemias. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-the-thalassemias.Last updated: September 28, 2015. Accessed: February 8, 2017.
8. Means RT, Glader B. Wintrobe's Clinical Hematology. Wolters Kluwer ; 2013 : p. 1142-1142
9. Van Vranken M. Evaluation of microcytosis.. Am Fam Physician. 2010; 82 (9): p.1117-22.
10. Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019; 133 (1): p.40-50. doi: 10.1182/blood-2018-06-856500 . | Open in Read by QxMD
11. Bross MH, Soch K, Smith-Knuppel T. Anemia in older persons.. Am Fam Physician. 2010; 82 (5): p.480-7.
12. Kaferle J, Strzoda CE. Evaluation of macrocytosis.. Am Fam Physician. 2009; 79 (3): p.203-8.
13. Tefferi A. Anemia in Adults: A Contemporary Approach to Diagnosis. Mayo Clin Proc. 2003; 78 (10): p.1274-1280. doi: 10.4065/78.10.1274 . | Open in Read by QxMD
14. Antony AC. Hematology: Basic Principles and Practice. Elsevier, Inc. ; 2018
15. Langan RC, Zawistoski KJ. Update on vitamin B12 deficiency.. Am Fam Physician. 2011; 83 (12): p.1425-30.
16. Brill JR, Baumgardner DJ. Normocytic anemia.. Am Fam Physician. 2000; 62 (10): p.2255-64.
17. Anaemia Management in Chronic Kidney Disease: Partial Update 2015. https://www.nice.org.uk/guidance/ng8/evidence/full-guideline-pdf-70545136. Updated: June 1, 2015. Accessed: May 27, 2020.
18. Carson JL, Guyatt G, Heddle NM, et al.. Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage. JAMA. 2016; 316 (19): p.2025. doi: 10.1001/jama.2016.9185 . | Open in Read by QxMD
19. Killick et al. Guidelines for the diagnosis and management of adult aplastic anaemia.. Br J Haematol. 2016; 172 (2): p.187-207. doi: 10.1111/bjh.13853 . | Open in Read by QxMD
20. Fanconi Anemia. https://www.ncbi.nlm.nih.gov/books/NBK1401/. Updated: March 8, 2018. Accessed: May 5, 2019.
21. Federman N, Sakamoto KM. Topics in pediatric leukemia--Fanconi's anemia: new insights.. MedGenMed. 2005; 7 (2): p.23.
22. Peffault de Latour R, Peters C, Gibson B, et al. Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.. Bone Marrow Transplant. 2015; 50 (9): p.1168-72. doi: 10.1038/bmt.2015.117 . | Open in Read by QxMD
23. Olson TS. Inherited aplastic anemia in children and adolescents. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/inherited-aplastic-anemia-in-children-and-adolescents?source=see_link#H3254301408.Last updated: September 13, 2016. Accessed: February 8, 2017.
24. Schrier SL, Bertuch AA. Acquired aplastic anemia in children and adolescents. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/acquired-aplastic-anemia-in-children-and-adolescents?source=see_link#H4.Last updated: January 19, 2017. Accessed: February 8, 2017.
25. Schrier SL, Mentzer WC, Rosmarin AG. Aplastic Anemia: Pathogenesis; Clinical Manifestations; and Diagnosis. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/aplastic-anemia-pathogenesis-clinical-manifestations-and-diagnosis?source=search_result&search=aplastic%20anemia&selectedTitle=1~150#H23.Last updated: September 8, 2016. Accessed: February 8, 2017.
26. Schrier SL. Treatment of aplastic anemia in adults. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/treatment-of-aplastic-anemia-in-adults?source=search_result&search=aplastic%20anemia&selectedTitle=2~150.Last updated: September 8, 2016. Accessed: February 8, 2017.
27. Fanconi Anemia. https://www.ncbi.nlm.nih.gov/books/NBK1401/. Updated: February 23, 2017. Accessed: August 9, 2017.
28. Weiss G, Goodnough LT. Anemia of chronic disease.. N Engl J Med. 2005; 352 (10): p.1011-23. doi: 10.1056/NEJMra041809 . | Open in Read by QxMD
29. Schrier SL, Camaschella C, Mentzer WC, Tirnauer JS. Anemia of Chronic Disease/Inflammation. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/anemia-of-chronic-disease-inflammation.Last updated: October 6, 2017. Accessed: August 9, 2017.
30. Bottomley SS, Fleming MD. Sideroblastic anemia: diagnosis and management.. Hematol Oncol Clin North Am. 2014; 28 (4): p.653-70, v. doi: 10.1016/j.hoc.2014.04.008 . | Open in Read by QxMD
31. Bottomley SS, Schrier SL, Tirnauer JS. Causes and Pathophysiology of the Sideroblastic Anemias. In: Post TW, ed. UpToDate. Waltham, MA: UpToDate. https://www.uptodate.com/contents/causes-and-pathophysiology-of-the-sideroblastic-anemias.Last updated: June 28, 2017. Accessed: August 9, 2017.
32. Means RT. Pure red cell aplasia. Blood. 2016; 128 (21): p.2504-2509. doi: 10.1182/blood-2016-05-717140 . | Open in Read by QxMD
33. Diamond-Blackfan Anemia. https://www.ncbi.nlm.nih.gov/books/NBK7047/. Updated: April 7, 2016. Accessed: August 9, 2017.
34. Narla A, Vlachos A, Nathan DG. Diamond Blackfan Anemia Treatment: Past, Present, and Future. Semin Hematol. 2011; 48 (2): p.117-123. doi: 10.1053/j.seminhematol.2011.01.004 . | Open in Read by QxMD
35. Herold G. Internal Medicine. Herold G ; 2014
36. Carson JL, Grossman BJ, Kleinman S et al. Red Blood Cell Transfusion: A Clinical Practice Guideline From the AABB. Ann Intern Med. 2012; 157 (1): p.49-58. doi: 10.7326/0003-4819-157-1-201206190-00429 . | Open in Read by QxMD
37. Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood. 2006; 107 (5): p.1747-50. doi: 10.1182/blood-2005-07-3046 . | Open in Read by QxMD
38. Quinto et al. Relationship between haemoglobin and haematocrit in the definition of anaemia. Tropical Medicine and International Health. 2006; 11 (8): p.1295-1302. doi: 10.1111/j.1365-3156.2006.01679.x . | Open in Read by QxMD
39. Yawn et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.. JAMA. 2014; 312 (10): p.1033-48. doi: 10.1001/jama.2014.10517 . | Open in Read by QxMD
40. Dietz et al. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.. Biol Blood Marrow Transplant. 2017; 23 (9): p.1422-1428. doi: 10.1016/j.bbmt.2017.05.022 . | Open in Read by QxMD
41. Hillman R, Ault K, Rinder H. Hematology in Clinical Practice. McGraw Hill Professional ; 2005
42. Bain BJ. Bone marrow aspiration. Journal of Clinical Pathology. 2001; 54 : p.657-663.